These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5989085)

  • 21. Treatment of chronic pain syndromes with iontophoresis of vinca alkaloids to the skin of patients.
    Csillik B; Knyihár-Csillik E; Szücs A
    Neurosci Lett; 1982 Jul; 31(1):87-90. PubMed ID: 7121897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Considerations on the therapy of acute leukemia with preparations obtained from Vinca rosea].
    Dardi G
    Minerva Pediatr; 1966 Jun; 18(19):987-9. PubMed ID: 5925764
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vincristine or vinblastine?].
    Hossfeld DK
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1790. PubMed ID: 923471
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of terminal pain in cancer patients by means of iontophoresis of vinca alkaloids.
    Szücs A; Csillik B; Knyihár-Csillik E
    Recent Results Cancer Res; 1984; 89():185-9. PubMed ID: 6695098
    [No Abstract]   [Full Text] [Related]  

  • 27. Vinca alkaloids and salivary-gland pain.
    Rose MS
    Lancet; 1967 Jan; 1(7483):213-4. PubMed ID: 4163141
    [No Abstract]   [Full Text] [Related]  

  • 28. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA; Williams LG; Torrance PM; Houghton PJ
    Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of acute infantile leukemia with vincristine sulfate].
    Jiménez de Asua F; Rodríguez BJ; Franceschi EM; Abaurrea C; Lucero LA
    Arch Argent Pediatr; 1964; 62(4):65-73. PubMed ID: 5834691
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with vincristine of some cases of acute leukemia in the child].
    Cocchi R
    Minerva Pediatr; 1966 Jun; 18(19):1000-2. PubMed ID: 5925758
    [No Abstract]   [Full Text] [Related]  

  • 33. THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
    JOHNSON IS; ARMSTRONG JG; GORMAN M; BURNETT JP
    Cancer Res; 1963 Sep; 23():1390-427. PubMed ID: 14070392
    [No Abstract]   [Full Text] [Related]  

  • 34. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
    Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM; Theologides A; Sheppard JR
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for the treatment of neoplastic disease.
    Whitelaw DM
    Can Med Assoc J; 1965 Dec; 93(23):1217-8. PubMed ID: 5842596
    [No Abstract]   [Full Text] [Related]  

  • 37. [New antitumor derivatives of vinblastine].
    Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and SAR of vinca alkaloid analogues.
    Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vincristine in the treatment of acute leukemias and leucosarcomas].
    Arcifa S; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(2):65-72. PubMed ID: 5932044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.